Bahrain, Kuwait approve Sotrovimab for emergency use in treating COVID-19

Bahrain, Kuwait approve Sotrovimab for emergency use in treating COVID-19
Bahrain, Kuwait approve Sotrovimab for emergency use in treating COVID-19

We show you our most important and recent visitors news details Bahrain, Kuwait approve Sotrovimab for emergency use in treating COVID-19 in the following article

Hind Al Soulia - Riyadh - Saudi Gazette report

MANAMA/KUWAIT — Bahrain and Kuwait on Wednesday approved Sotrofimab for emergency use, a new drug by GlaxoSmithKline (GSK) for the treatment of COVID-19, official news agencies of both countries reported.

Earlier this week, the United Arab Emirates gave Sotrofimab a go-ahead for the treatment of COVID-19, becoming the first country in the world to approve the drug for emergency use following the US Food and Drug Administration's approval

In a statement carried by the Bahrain News Agency (BNA), Bahrain's National Health Regulatory Authority (NHRA) said that its decision to add Sotrofimab to COVID-19 treatment protocols follows emergency use approval by the FDA as well a comprehensive review of GSK's clinical trials.

“Sotrovimab-VIR-7831” develops “monoclonal antibodies” and will be used to treat infected adults and adolescents with mild to moderate COVID-19 symptoms who are at risk of their condition deteriorating and resulting in hospitalization, the NHRA said in the statement.

According to the BNA report, safety and efficacy evidence demonstrates a reduction in the number of cases requiring hospitalization for more than 24 hours and a reduction in the number of fatalities by 85 percent, when administered at an early stage of treatment.

Meanwhile, the Kuwaiti health ministry said it has approved the drug for treating light and medium coronavirus cases.

Dr. Abdullah Al-Badr, the assistant undersecretary for medicines and nutrition supervision, told the Kuwait News Agency that the drug is used for such cases among adults and children aged 12 and above.

He has pointed out that the medicine is used for persons of 65 years of age and above, but not for hospitalized patients who need oxygen due to infection with COVID-19.


These were the details of the news Bahrain, Kuwait approve Sotrovimab for emergency use in treating COVID-19 for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at Saudi Gazette and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV On World Hepatitis Day, WHO calls to eliminate disease by 2030
NEXT Deadly heat wave slams Canada, US